REVIEW PAPER
Modern techniques in organ transplantation
More details
Hide details
1
Uniwersytet Medyczny w Lublinie
2
Klinika Neurologii Dziecięcej III Katedry Pediatrii, Uniwersytet Medyczny w Lublinie
3
Klinika Endokrynologii i Diabetologii Dziecięcej III Katedra Pediatrii Uniwersytet Medyczny w Lublinie
Corresponding author
Maria Golebiowska
Uniwersytet Medyczny w Lublinie Klinika Neurologii Dziecięcej ul. prof. A Gębali 6, 20-093 Lublin
Med Og Nauk Zdr. 2017;23(4):230-234
KEYWORDS
TOPICS
ABSTRACT
Abstract:
Organ transplantation is one of the most intensively developing fields of medicine, the blooming period of which began
at the turn of the century with the first successful organ transplants, giving patients hope for a second chance and health.
Currently, after the discovery of the surgical and immunological aspects of transplantation, the most pressing problem
is the lack of organs. Scientists are also facing new challenges with the introduction of face transplantation procedures,
transplantation in the newborn, and the planned procedure for head transplant.
The purpose of the study is to present the latest technical challenges of transplantation: organ culture and 3D bioprinting,
head transplantation, and xenotransplantation.
Numerous studies show remarkable progress in the synthesis of iPSC organs – the first attempts of regeneration techniques
of the heart, liver, bones and cornea mark the beginning of regenerative medicine and a new era in transplantation, where
synthetic organs replace the need for human donors. The 3D bioprinting technique seems necessary in the planning of the
above-mentioned achievements, which will enable a harmonious reconstruction of anatomical and histological structures
and dependencies. Intensive research is also being carried out from the aspect of head graft, where the most important
dilemmas of surgery are, e.g. deep hypothermia, anastomosis of the spinal cord, and subsequent damage to the spinothalamic
tract. Additionally, numerous ethical and moral arguments related to the surgery are also the cause of disquiet.
Although, in the last two decades transplantation has been experiencing tremendous technical progress, there are still
many technical and ethical challenges related with these procedures.
REFERENCES (35)
1.
Hamilton D. A History of Organ Transplantation: Ancient Legends to Modern Practice. University of Pittsburgh Press, Pittsburgh; 2012.
2.
Lay K. Newborn baby is youngest organ donor in Britain. The Times. U.K.; 2015.
3.
Lamba N, Holsgrove D, Broekman ML. The history of head transplan¬tation: a review. Acta Neurochir. 2016; 158: 2239–2247, doi: 10.1007/ s00701–016–2984–0.
4.
Carrel A. (2014) Nobel lecture: Suture of blood-vessels and transplan¬tation of organs.
http://www.nobelprize.org/nobe... laureates/1912/carrel-lecture.html. Accessed 07 August 2017.
5.
White RJ, Wolin LR, Massopust LC, Taslitz N, Verdura J. Cephalic exchange transplantation in the monkey. Surgery; 1971; 70 (1): 135–139.
6.
Li PW, Zhao X, Zhao YL, Wang BJ, Song Y, Shen ZL et al. A cross¬-circulated bicephalic model of head transplantation. Surg Neurol Int. 2016; 7 (Suppl 24): 623–625.
7.
Canavero S. HEAVEN: The head anastomosis venture project outline for the first human head transplantation with spinal linkage (GEMINI) Surg Neurol Int. 2013; 4 (Suppl 1): 335–342.
8.
Ren XP, Canavero S. Human head transplantation. Where do we stand and a call to arms. Surg Neurol Int. 2016; 7: 11. doi: 10.4103/2152– 7806.175074.
9.
Canavero S, Ren X, Kim C-Y, Rosati E. Neurologic foundations of spinal cord fusion (GEMINI). Surgery 2016; 160 (1): 11–19.
10.
Cho Y, Borgens RB. Polymer and nano-technology applications for repair and reconstruction of thecentral nervous system. Exp Neurol. 2012; 233: 126–44.
11.
Borgens RB. Cellular engineering: Molecular repair of membranes to rescue cells of the damaged nervous system. Neurosurgery. 2001; 49: 370–8.
12.
Cuoco JA. Reproductive implications of human head transplantation. Surg Neurol Int. 2016; 7: 48.
13.
Canavero S, Ren XP, Kim CY. HEAVEN: The Frankenstein effect, CNS Neurosci Ther. 2017 Jun; 23 (6): 535–541. doi: 10.1111/cns.12700.
15.
European Directorate for the Quality of Medicines & Health Care of the Council of Europe. International Figures on donation and trans-plantation. Vol 20; 2015.
16.
Ginossar T, Benavidez J, Gilloy ZD, Attreya AK, Ngyuen H, Ben¬tley J. Ethnic/Racial, Religious and Demographic Predictors of Or¬gan Donor Registration Status Among Young Adults in the Southwe¬stern United States. Prog Transplant. 2017 Mar; 27 (1): 16–22. doi: 10.1177/1526924816665367. Epub 2016 Sep 20.
17.
Ghods AJ, Savaj S. Iranian Model of Paid and Regulated Living – Un¬related Kidney Donation. CJASN Nov 2006; 1 (6): 1136–1145.
18.
Shimazono Y. The state of the international organ trade: a provisional picture based on integration of available information. World Health Organization Bulletin. 2007.
19.
Paul NW, Caplan A, Shapiro ME, Els C, Allison KC, Paul HL et al. Human rights violations in organ procurement practice in China. BMC Med Ethics 2017; 18: 11.
20.
Burcin E, Ezzelarab M, Hara H, van der Windt DJ, Wijkstrom M, Bottino R et al. Clinical xenotransplantation: the next medical revolution? The Lancet 2012; 379: 9816, 672–683.
21.
Hilfiker A, Ramm R, Goecke T, Haverich A. Heart valve transplantation: the urgent need for non-immunogenic porcine heart valve matrices. Xenotransplantation. 2013; 20: 1.
22.
Aboudna GM, Ethical issues in organ transplantation. Med Princ Pract. 2003; 12: 54–69.
23.
Vermeulen N, Haddow G, Seymour T, Faulkner-Jones A, Shu W. 3D bioprint me: a socioethical view of bioprinting human organs and tissues. J Med Ethics 2017; 0: 1–7. doi:10.1136/medethics-2015–103347.
24.
Rosner F. Contemporary Biomedical Ethical Issues and Jewish Law. KTAV Publishing House Inc., 2007.
25.
Krishna M, Lepping P. Ethical debate: Ethics of xeno-transplantation, BJMP 2011; 4 (3): 425.
26.
Hagelin J. Public opinion surveys about xenotransplantation. Xeno¬transplantation. 2004 Nov; 11 (6): 551–8.
27.
Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448 (7151); 313–317.
28.
Fujita J, Fukuda K. Future Prospects for Regenerated Heart Using In¬duced Pluripotent Stem Cells. J Pharmacol Sci. 2014; 125, 1–5.
29.
Jung JP, Bhuiyan DB, Ogle BM. Solid organ fabrication: comparison of decellularization to 3D bioprinting Biomaterials Research. 2016; 20: 27.
30.
Takebe T, Zhang RR, Koike H, Kimura M, Yoshizawa E, Enomura M et al. Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature Protocols. 2014; 9, 396–409.
31.
Caralt M, Velasco E, Lanas A, Baptista PM. Liver bioengineering from the stage of liver decellularized matrix to the multiple cellular actors and bioreactor special effects Organogenesis 2014; 10: 2, 250–259.
32.
Palomo ABA, Lucas M, Dilley RJ, McLenachan S, Chen FK, Requena J, Sal MF, et al. The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation J Clin Med. 2014 Jun; 3 (2): 373–387.
33.
Araki R, Uda M, Hoki Y et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature. 2013; 494: 100–104.
34.
Wang L, Cao J, Wang Y, Lan T, Liu L, Wang W, et al. Immunogenicity and functional evaluation of iPSC-derived organs for transplantation. Cell Discovery. 2015; 1, 15015.
35.
Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Bio¬technol. 2014; 32: 773–85.